HYALGAN
LIVE

Serial Number

79202959

Owner

Fidia Farmaceutici S.p.A.

Attorney

Andrew N. Fredbeck

Filing Date

Jul 19, 2016

Add to watchlist:

No watchlists yet
View on USPTO

HYALGAN Trademark

Serial Number: 79202959 • Registration: 5388830

HYALGAN is a trademark filed by Fidia Farmaceutici S.p.A. on July 19, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Fidia Farmaceutici S.p.A.

Via Ponte della Fabbrica 3/A

Entity Type: 99

FIDIA FARMACEUTICI S.p.A.

Via Ponte della Fabbrica, 3/A
Abano Terme (PD) I-35031 , IT

Entity Type: 09

Trademark Details

Filing Date

July 19, 2016

Registration Date

January 30, 2018

Published for Opposition

November 14, 2017

Goods & Services

[ Surgical apparatus and devices; syringes, cannulas, medical and surgical instruments for administering pharmaceutical and veterinary preparations; medical, surgical, veterinary devices and apparatus for the treatment of traumatic and degenerative joint pathologies and for orthopedic surgery ]

Pharmaceutical and medical preparations for the treatment of arthrosis and osteoarthritis; pharmaceutical and medical preparations for the treatment of traumatic and degenerative joint pathologies and for use during orthopedic surgery; pharmaceutical and medical preparations for the treatment of rheumatological diseases; analgesic preparations; pharmaceutical and medical preparations for the treatment of diseases of the muscular and skeletal system; [ veterinary preparations for the treatment of the joints and for the treatment of traumatic and degenerative joint pathologies and of diseases of the muscular and skeletal system; ] Syringes sold filled with the aforementioned preparations

Filing History

INTERNATIONAL REGISTRATION RENEWED
Jul 9, 2026 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Nov 7, 2025 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Oct 1, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Oct 1, 2025 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 24, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 24, 2024 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Sep 24, 2024 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 23, 2024 APRE
TEAS SECTION 71 RECEIVED
Jan 22, 2024 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 30, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jun 4, 2022 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 6, 2020 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 30, 2020 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 15, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 3, 2018 FICS
FINAL DISPOSITION PROCESSED
May 3, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 30, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 30, 2018 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 18, 2018 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 6, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2017 CRFA
ASSIGNED TO LIE
Sep 20, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2017 TROA
REFUSAL PROCESSED BY IB
Apr 2, 2017 RFNT
APPLICATION FILING RECEIPT MAILED
Mar 17, 2017 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 15, 2017 RFCS
REFUSAL PROCESSED BY MPU
Mar 15, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 14, 2017 RFCR
NON-FINAL ACTION WRITTEN
Mar 13, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 13, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 13, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 9, 2017 REPR